HRP20220252T1 - Nova upotreba n,n-bis-2-merkaptoetil izoftalamida - Google Patents
Nova upotreba n,n-bis-2-merkaptoetil izoftalamida Download PDFInfo
- Publication number
- HRP20220252T1 HRP20220252T1 HRP20220252TT HRP20220252T HRP20220252T1 HR P20220252 T1 HRP20220252 T1 HR P20220252T1 HR P20220252T T HRP20220252T T HR P20220252TT HR P20220252 T HRP20220252 T HR P20220252T HR P20220252 T1 HRP20220252 T1 HR P20220252T1
- Authority
- HR
- Croatia
- Prior art keywords
- bis
- pharmaceutically acceptable
- mercaptoethyl isophthalamide
- nbmi
- isophthalamide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Toxicology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB201613535 | 2016-08-05 | ||
| EP17793720.8A EP3493849B1 (en) | 2016-08-05 | 2017-08-04 | New use of n,n-bis-2-mercaptoethyl isophthalamide |
| PCT/GB2017/052306 WO2018025049A1 (en) | 2016-08-05 | 2017-08-04 | New use of n,n-bis-2-mercaptoethyl isophthalamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20220252T1 true HRP20220252T1 (hr) | 2022-04-29 |
Family
ID=60202272
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HRP20220252TT HRP20220252T1 (hr) | 2016-08-05 | 2017-08-04 | Nova upotreba n,n-bis-2-merkaptoetil izoftalamida |
Country Status (30)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB202005057D0 (en) | 2020-04-06 | 2020-05-20 | Emeramed Ltd | New Use |
| WO2026037909A1 (en) * | 2024-08-16 | 2026-02-19 | Emeramed Limited | N,n-bis-2-mercaptoethyl isophthalamide for use in the treatment of pain |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6586600B2 (en) | 2000-12-06 | 2003-07-01 | University Of Kentucky Research Foundation | Multidentate sulfur-containing ligands |
| US8950583B2 (en) * | 2008-12-06 | 2015-02-10 | Ermes Medical Company Limited | Method to remove heavy metals from a mammal |
| US20120122787A1 (en) * | 2009-07-10 | 2012-05-17 | Rong Li | Methods for treating polycystic kidney disease (pkd) or other cyst forming diseases |
| JP2013505963A (ja) | 2009-09-28 | 2013-02-21 | ユニヴァーシティ オブ ケンタッキー リサーチ ファウンデイション | 汚染された環境から元素を除去するチオール含有化合物およびその使用方法 |
| US8575218B2 (en) | 2009-09-28 | 2013-11-05 | The University Of Kentucky Research Foundation | Thiol-containing compounds for the removal of elements from tissues and formulations therefor |
| US20110237776A1 (en) | 2010-03-25 | 2011-09-29 | Haley Boyd E | Aromatic compounds with sulfur containing ligands |
| US8426368B2 (en) | 2010-03-25 | 2013-04-23 | The University Of Kentucky Research Foundation | Method of ameliorating oxidative stress and supplementing the diet |
-
2017
- 2017-08-04 LT LTEPPCT/GB2017/052306T patent/LT3493849T/lt unknown
- 2017-08-04 HU HUE17793720A patent/HUE057782T2/hu unknown
- 2017-08-04 EP EP21211493.8A patent/EP4029497A1/en not_active Withdrawn
- 2017-08-04 CN CN202511855908.5A patent/CN121926911A/zh active Pending
- 2017-08-04 MX MX2019000978A patent/MX387853B/es unknown
- 2017-08-04 WO PCT/GB2017/052306 patent/WO2018025049A1/en not_active Ceased
- 2017-08-04 ES ES17793720T patent/ES2907838T3/es active Active
- 2017-08-04 SI SI201731094T patent/SI3493849T1/sl unknown
- 2017-08-04 SM SM20220109T patent/SMT202200109T1/it unknown
- 2017-08-04 BR BR112019002130-2A patent/BR112019002130A2/pt not_active Application Discontinuation
- 2017-08-04 PL PL17793720T patent/PL3493849T3/pl unknown
- 2017-08-04 DK DK17793720.8T patent/DK3493849T3/da active
- 2017-08-04 RS RS20220147A patent/RS62924B1/sr unknown
- 2017-08-04 MD MDE20190671T patent/MD3493849T2/ro unknown
- 2017-08-04 CN CN201780046065.1A patent/CN109562179A/zh active Pending
- 2017-08-04 JP JP2019505490A patent/JP6926192B2/ja active Active
- 2017-08-04 KR KR1020197003227A patent/KR102538388B1/ko active Active
- 2017-08-04 HR HRP20220252TT patent/HRP20220252T1/hr unknown
- 2017-08-04 PT PT177937208T patent/PT3493849T/pt unknown
- 2017-08-04 MA MA45855A patent/MA45855B1/fr unknown
- 2017-08-04 EA EA201990443A patent/EA201990443A1/ru unknown
- 2017-08-04 AU AU2017305661A patent/AU2017305661B2/en active Active
- 2017-08-04 US US16/318,842 patent/US20190240173A1/en not_active Abandoned
- 2017-08-04 EP EP17793720.8A patent/EP3493849B1/en active Active
- 2017-08-04 SG SG11201900565RA patent/SG11201900565RA/en unknown
- 2017-08-04 UA UAA201902172A patent/UA125394C2/uk unknown
- 2017-08-04 MY MYPI2019000127A patent/MY199733A/en unknown
-
2019
- 2019-01-28 ZA ZA2019/00594A patent/ZA201900594B/en unknown
- 2019-01-29 CL CL2019000229A patent/CL2019000229A1/es unknown
- 2019-01-29 IL IL264538A patent/IL264538B2/en unknown
- 2019-02-01 PH PH12019500237A patent/PH12019500237A1/en unknown
-
2022
- 2022-03-01 CY CY20221100175T patent/CY1125039T1/el unknown
-
2024
- 2024-12-06 US US18/972,315 patent/US20250325503A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20250250T1 (hr) | Derivati 7‑benzil‑4‑(2‑metilbenzil)‑2,4,6,7,8,9‑heksahidroimidazo[1,2‑a]pirido[3,4‑e] pirimidin‑5(1h)‑ona, njihove soli i njihova upotreba u terapiji | |
| HUE059677T2 (hu) | Áthidalt triciklusos karbamoilpiridon-vegyületek és ezek gyógyszerészeti alkalmazása | |
| EP3684334C0 (en) | PHARMACEUTICAL COMPOSITIONS OF ROFLUMILAST IN AQUEOUS MIXTURES OF PHARMACEUTICALLY ACCEPTABLE WATER-MISCIBLE SOLVENTS | |
| ZA201906451B (en) | 4-pyridone compound or salt thereof, and pharmaceutical composition and formulation including same | |
| MX392213B (es) | Composiciones farmacéuticas que comprenden sales de glicopirrolato y 1,1-difluoroetano. | |
| ES2850277R1 (es) | Composiciones de administración farmacéutica y usos de las mismas | |
| HRP20240351T1 (hr) | Cot modulatori i postupci za njihovu uporabu | |
| EP3318282A4 (en) | AGGREGATE COMPOSITION CARRIER AND COMPOSITION THEREOF | |
| HRP20241221T1 (hr) | POLICIKLIČNI KARBAMOILPIRIDONSKI DERIVATI ZA LIJEČENJE HIV-a | |
| ECSP17044282A (es) | Formulación de relación fija de insulina glargina/lixisenatida | |
| EP4041734C0 (en) | DERIVATIVES HAVING A 1,2,3,4-TETRAHYDRONAPHTHALENE FRACTION OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM | |
| IL289932A (en) | History of 6,3-diamino-pyridazin-3-yl, pharmaceutical preparations containing them and their use as pro-apoptotic agents | |
| MX387725B (es) | Composición farmacéutica. | |
| CY1123844T1 (el) | Φαρμακευτικες συνθεσεις και χρησεις που απευθυνονται σε διαταραχες λυσοσωμιακης αποθηκευσης | |
| UY36117A (es) | Composiciones farmacéuticas para el tratamiento de enfermedades infecciosas. | |
| PH12017502322B1 (en) | Therapeutic agent for fibrosis | |
| IL289943A (en) | Medicinal and/or pharmaceutical compositions for insertion into a blister, preparation and uses | |
| EP3773654C0 (en) | POLYPHARMACEUTICAL DRUG COMPOSITIONS AND ASSOCIATED METHODS | |
| EA201991287A1 (ru) | Твердые фармацевтические композиции на основе тикагрелора для перорального применения | |
| MY198553A (en) | Pharmaceutical composition comprising metformin and lobeglitazone | |
| EP3921322C0 (en) | PHOSPHORUS IMIDAZOQUINOLINE AMINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS AND THERAPEUTIC METHODS THEREOF | |
| IL264538B2 (en) | A new use of n,n-bis-2-mercaptoethyl isophthalamide | |
| EP3813799C0 (en) | PHARMACEUTICAL FORMULATION WITH IMPROVED SOLUBILITY AND BIOAVAILABILITY | |
| ZA202107580B (en) | Formulation of (e)-2,4,6-trimethoxystyryl-3-[(carboxymethyl)amino]-4- methoxybenzylsulphone with enhanced stability and bioavailability | |
| IL283719A (en) | Colonic drug delivery formulation |